We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
Histone modification by histone acetyltransferases (HAT) and histone deacetylases (HDAC) can control major aspects of transcriptional regulation. NOC2L represents a novel HDAC-independent inhibitor of histone acetyltransferase (INHAT) (Hublitz et al., 2005 [PubMed 16322561]).[supplied by OMIM, Mar 2008]
Q9Y3T9 [Direct mapping] Nucleolar complex protein 2 homolog
Show all
MEMSAT3 predicted membrane proteins Phobius predicted membrane proteins THUMBUP predicted membrane proteins Predicted intracellular proteins Protein evidence (Kim et al 2014) Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000122 [negative regulation of transcription from RNA polymerase II promoter] GO:0002903 [negative regulation of B cell apoptotic process] GO:0003682 [chromatin binding] GO:0003714 [transcription corepressor activity] GO:0005488 [binding] GO:0005515 [protein binding] GO:0005634 [nucleus] GO:0005654 [nucleoplasm] GO:0005730 [nucleolus] GO:0006351 [transcription, DNA-templated] GO:0006915 [apoptotic process] GO:0031491 [nucleosome binding] GO:0031497 [chromatin assembly] GO:0032066 [nucleolus to nucleoplasm transport] GO:0034644 [cellular response to UV] GO:0035067 [negative regulation of histone acetylation] GO:0042393 [histone binding] GO:0044822 [poly(A) RNA binding] GO:0070491 [repressing transcription factor binding] GO:2001243 [negative regulation of intrinsic apoptotic signaling pathway]
